Nuclear receptor PPAR and hepatology: pathophysiological and therapeutical aspects

Dharancy S, Louvet A, Hollebecque A, Desreumaux P, Mathurin P, Dubuquoy L.
Inserm U795, Boulevard du Professeur-Jules-Leclercq, 59037 Lille, France. This email address is being protected from spambots. You need JavaScript enabled to view it.
Gastroenterol Clin Biol. 2008 Mar;32(3):339-50.

Read more...

Colonization of mice by Candida albicans is promoted by chemically induced colitis and augments inflammatory responses through galectin-3.

Jawhara S, Thuru X, Standaert-Vitse A, Jouault T, Mordon S, Sendid B, Desreumaux P, Poulain D.

Inserm U 799, Physiopathologie des Candidoses, Faculté de Médecine, Centre Hospitalier Régional Universitaire de Lille, Institut Fédératif de Recherche 114, Université Lille 2, , Lille, France.
J Infect Dis. 2008 Apr 1;197(7):972-80.

Read more...

PPARgamma agonists as a new class of effective treatment for ulcerative colitis.

Desreumaux P, Dubuquoy L.
University of Lille 2, Huriez Hospital, Digestive Tract Diseases and Nutrition Department, Lille, France.
Inflamm Bowel Dis. 2008 Sep 17.

Crohn's disease: beyond antagonists of tumour necrosis factor.

Peyrin-Biroulet L, Desreumaux P, Sandborn WJ, Colombel JF.
Hôpital Claude Huriez, Centre Hospitalier Universitaire de Lille, Lille, France.
Lancet. 2008 Jul 5;372(9632):67-81.

Read more...